Kevin Fenix

Research Interests

Cancer Cell Biology Cellular Immunology Immunological and Bioassay Methods Tumour Immunology Cancer Biology and Clinical Oncology Immunology and Infection

Dr Kevin Fenix

School of Medicine

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Dr Kevin Fenix, PhD is a Chief Medical Scientist with the Department of Medical Oncology, The Queen Elizabeth Hospital located at the Basil Hetzel Institute for Translational Health Research. He is also a Cancer Council Research Fellow and Affiliate Senior Lecturer with the Solid Tumour Research Group, School of Medicine, College of Health.
 
His current research utilises both patient samples and clinically relevant in vitro and in vivo models to find new treatment modalities for infections and cancer. Dr Fenix has successfully supervised Honours, Master and PhD students to completion and is a recipient of multiple competitive research grants to support his research.

I am a Chief Medical Scientist at the Department of Medical Oncology, The Queen Elizabeth Hospital. My research interests include Cancer Immunotherapy, Cancer Biology, Immunobiology and Host/Microbe Interactions. Additionally, I collaborate closely with the Upper GI and ENT Surgery Departments at the Basil Hetzel Institute for Translational Health Research. Currently, I am identifying treatment modalities for Colorectal Cancer and Head and Neck Cancer.

Projects related to this work are available for HDR, Honours and Third Year Students. Potential students can apply for competitive scholarships for Honours, Masters and PhD (Top-Up) offered by the Basil Hetzel Institute.

Current projects include:

  • Identifying distinct tumour-infiltrating immune cells with prognostic capacity for cancer metastasis and patient survival.

  • Developing T cell-based therapies for cancer.

  • Understanding and exploiting the tumour microbiome to develop new cancer treatments.

     

Date Position Institution name
2026 - ongoing Affiliate Senior Lecturer Adelaide University
2026 - ongoing Chief Medical Scientist Queen Elizabeth Hospital
2018 - 2026 Postdoctoral Research Fellow The University of Adelaide

Date Type Title Institution Name Country Amount
2024 Fellowship Cancer Council SA Mid-Career Research Fellowship Cancer Council SA Australia -
2018 Fellowship The Hospital Research Foundation Early Career Fellowship The Hospital Research Foundation Australia -
2017 Award Dean’s Commendation for Thesis Excellence The University of Adelaide Australia -
2012 Scholarship Australian Postgraduate Award The University of Adelaide Australia -
2010 Research Award Derrick Rowley Prize for Honours in Microbiology and Immunology The University of Adelaide Australia -

Language Competency
English Can read, write, speak, understand spoken and peer review
Filipino; Pilipino Can read, write, speak and understand spoken

Date Institution name Country Title
2017 University of Adelaide Australia PhD
2010 University of Adelaide, Adelaide Australia Bsc (Hons)
2009 University of Adelaide, Adelaide Australia Bsc (Biomedical Science)

Year Citation
2026 Ramezanpour, M., Bouras, G., Feizi, S., Fenix, K. A., Houtak, G., Chegeni, N., . . . Vreugde, S. (2026). Nasal organoids as optimal models for studying structure and function of primary nasal epithelial cell cultures. Biochimica et Biophysica Acta - General Subjects, 1870(6), 130936-1-130936-9.
DOI Scopus1 WoS1
2026 Ambachew, S., Ramezanpour, M., Cooksley, C. M., Feizi, S., Awad, M., Fenix, K. A., . . . Vreugde, S. (2026). Interspecies Biofilm Dynamics Among Staphylococci: Inflammatory Contributions to Chronic Rhinosinusitis. International Forum of Allergy and Rhinology, 12 pages.
DOI Scopus1 WoS1
2026 Ambachew, S., Ramezanpour, M., Cooksley, C. M., Barry, E. F., Durr, L., Fenix, K. A., . . . Vreugde, S. (2026). Biofilm Exoproteins From Staphylococcus Species Impede Re-Epithelialization of Nasal Epithelial Cells During Wound Healing and Cease Ciliary Beat Frequency. International Forum of Allergy and Rhinology, 14 pages.
DOI Scopus3 WoS3 Europe PMC1
2026 Ambachew, S., Ramezanpour, M., Cooksley, C. M., Shaghayegh, G., Burdon, I., Barry, E. F., . . . Vreugde, S. (2026). Staphylococcus aureus and Staphylococcus lugdunensis Act in Concert to Disrupt the Nasal Epithelial Barrier. Clinical and Translational Allergy, 16(5), e70177-1-e70177-14.
DOI
2026 Tyllis, T. S., Norton, T. S., Abbott, C., McPeake, D. J., Fenix, K. A., Wilson, J. J., . . . Comerford, I. (2026). B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection. National Academy of Sciences. Proceedings, 123(27), e2535787123-1-e2535787123-12.
DOI
2025 Syphers, J. L., Wright, J. A., Liu, S., Gee, Y. S., Gao, F., Mudududdla, R., . . . Baell, J. B. (2025). Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids. Journal of Medicinal Chemistry, 68(8), 8065-8090.
DOI Scopus5 WoS6 Europe PMC3
2025 Burdon, I., Bouras, G., Fenix, K., Yeo, K., Connell, J., Cooksley, C., . . . Psaltis, A. J. (2025). Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome. International Forum of Allergy and Rhinology, 15(9), 989-992.
DOI WoS1 Europe PMC2
2025 Sharma, A., Sangiolo, D., Rosato, A., Pu, J., Hou, J., Tettamanti, S., . . . Schmidt-Wolf, I. G. H. (2025). Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. Cancer Immunology Immunotherapy, 74(12), 361.
DOI Scopus2 Europe PMC1
2024 Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11.
DOI Scopus24 WoS23 Europe PMC14
2024 Connell, J. T., Yeo, K., Bouras, G., Bassiouni, A., Fenix, K., Cooksley, C., . . . Psaltis, A. J. (2024). Enhanced phylogenetic insights into the microbiome of chronic rhinosinusitis through the novel application of long read 16S rRNA gene amplicon sequencing.. Rhinology, 0(0), 0.
DOI Scopus5 WoS7 Europe PMC4
2024 Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16.
DOI Scopus4 WoS3 Europe PMC2
2024 Sharma, A., Ren, X., Rosato, A., Sangiolo, D., Wang, Z., Tettamanti, S., . . . Schmidt-Wolf, I. G. H. (2024). Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.. Cancer Immunol Immunother, 73(2), 21.
DOI Scopus14 WoS14 Europe PMC13
2024 Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. Journal of Medical Microbiology, 73(2), 001799-1-001799-18.
DOI Scopus9 WoS8 Europe PMC7
2024 Li, C. M. Y., Briggs, M. T., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.. Clin Exp Med, 24(1), 53.
DOI Scopus14 WoS14 Europe PMC12
2024 Houtak, G., Nepal, R., Bouras, G., Shaghayegh, G., Bennett, C., Finnie, J., . . . Vreugde, S. (2024). Staphylococcus aureus Biofilm-Secreted Factors Cause Mucosal Damage, Mast Cell Infiltration, and Goblet Cell Hyperplasia in a Rat Rhinosinusitis Model. International Journal of Molecular Sciences, 25(6), 3402-1-3402-22.
DOI Scopus9 WoS8 Europe PMC8
2024 Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221-1-110221-16.
DOI Scopus10 WoS10 Europe PMC9
2024 Yeo, K., Connell, J., Bouras, G., Smith, E., Murphy, W., Hodge, J. -C., . . . Fenix, K. A. (2024). A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues. Arch Microbiol, 206(6), 248-1-248-14.
DOI Scopus27 WoS26 Europe PMC17
2024 Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), e7352-1-e7352-11.
DOI Europe PMC1
2024 Connell, J. T., Bouras, G., Yeo, K., Fenix, K., Cooksley, C., Bassiouni, A., . . . Psaltis, A. J. (2024). Characterising the allergic fungal rhinosinusitis microenvironment using full-length 16S rRNA gene amplicon sequencing and fungal ITS sequencing.. Allergy, 79(11), 3082-3094.
DOI Scopus14 WoS11 Europe PMC7
2024 Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?. Pathogens, 13(10), 826-1-826-20.
DOI Scopus3 WoS3 Europe PMC3
2023 Ying Li, C. M., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. (2023). Use of cytokine-induced killer cell therapy in colorectal cancer patients: a systematic review and meta-analysis.
DOI
2023 Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages.
DOI Scopus4 WoS4 Europe PMC3
2023 Houtak, G., Nepal, R., Bouras, G., Shaghayegh, G., Bennett, C., Finnie, J., . . . Vreugde, S. (2023). <i>Staphylococcus aureus</i> biofilm secreted factors cause mucosal damage, mast cell infiltration and goblet cell hyperplasia in a rat rhinosinusitis model.
DOI
2023 Dhakal, B., Tomita, Y., Drew, P., Price, T., Maddern, G., Smith, E., & Fenix, K. (2023). Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules, 28(8), 3624.
DOI Scopus22 WoS20 Europe PMC20
2023 Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17.
DOI Scopus24 WoS25 Europe PMC20
2023 Shaghayegh, G., Cooksley, C., Bouras, G., Nepal, R., Houtak, G., Panchatcharam, B. S., . . . Vreugde, S. (2023). Staphylococcus aureus biofilm properties and chronic rhinosinusitis severity scores correlate positively with total CD4+ T-cell frequencies and inversely with its Th1, Th17 and regulatory cell frequencies. Immunology, 170(1), 120-133.
DOI Scopus19 WoS17 Europe PMC13
2023 Krishnan, S. T., Winkler, D., Creek, D., Anderson, D., Kirana, C., Maddern, G. J., . . . Voelcker, N. H. (2023). Staging of colorectal cancer using lipid biomarkers and machine learning.. Metabolomics, 19(10), 11 pages.
DOI Scopus25 WoS24 Europe PMC14
2022 Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages.
DOI Scopus15 WoS15 Europe PMC14
2022 Mahnaz, R., Harrison, B., Hon, K., Gohar, S., Hadi, R., Aaron, F. K., . . . Sarah, V. (2022). Characterization of human nasal organoids from chronic rhinosinusitis patients.. Biology open, 11(8), 1-8.
DOI Scopus8 WoS6 Europe PMC4
2021 Tyllis, T. S., Fenix, K. A., Norton, T. S., Kara, E. E., McKenzie, D. R., David, S. C., . . . Comerford, I. (2021). CXCR5⁺CD8⁺ T cells shape antibody responses In Vivo following protein immunisation and peripheral viral infection. Frontiers in Immunology, 12, 626199-1-626199-14.
DOI Scopus16 WoS16 Europe PMC13
2021 Balakrishnan, B., Liang, Q., Fenix, K., Tamang, B., Hauben, E., Ma, L., & Zhang, W. (2021). Combining the anticancer and immunomodulatory effects of astragalus and shiitake as an integrated therapeutic approach. Nutrients, 13(8), 16 pages.
DOI Scopus38 WoS34 Europe PMC24
2020 Whyte, C. E., Osman, M., Kara, E. E., Abbott, C., Foeng, J., McKenzie, D. R., . . . McColl, S. R. (2020). ACKR4 restrains antitumor immunity by regulating CCL21. Journal of Experimental Medicine, 217(6), 1-S4.
DOI Scopus31 WoS30 Europe PMC31
2020 Goggin, R., Bennett, C., Ramezanpour, M., Hu, H., Fenix, K., Bassiouni, A., . . . Vreugde, S. (2020). Association between viral infection and increased mucosal eosinophils and CD8<sup>+</sup>CD103<sup>+</sup> T cells in chronic rhinosinusitis. International Forum of Allergy and Rhinology, 10(8), 978-980.
DOI Scopus1 WoS1 Europe PMC1
2020 Fenix, K., Wijesundara, D. K., Cowin, A. J., Grubor-Bauk, B., & Kopecki, Z. (2020). Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis.. International Journal of Molecular Sciences, 21(19), 7228-1-7228-13.
DOI Scopus35 WoS32 Europe PMC29
2018 Kara, E. E., Bastow, C. R., McKenzie, D. R., Whyte, C. E., Fenix, K. A., Babb, R., . . . McColl, S. R. (2018). Atypical chemokine receptor 4 shapes activated B cell fate. Journal of Experimental Medicine, 215(3), 801-813.
DOI Scopus22 WoS22 Europe PMC26
2017 McKenzie, D., Kara, E., Bastow, C., Tyllis, T., Fenix, K., Gregor, C., . . . McColl, S. (2017). IL-17-producing γδ T cells switch migratory patterns between resting and activated states. Nature Communications, 8(15632), 15632-1-15632-13.
DOI Scopus110 WoS105 Europe PMC105
2016 Leong, Y., Chen, Y., Ong, H., Wu, D., Man, K., Deleage, C., . . . Yu, D. (2016). CXCR5⁺ follicular cytotoxic T cells control viral infection in B cell follicles. Nature Immunology, 17(10), 1187-1196.
DOI Scopus419 WoS410 Europe PMC437
2015 Kara, E., McKenzie, D., Bastow, C., Gregor, C., Fenix, K., Ogunniyi, A., . . . McColl, S. (2015). CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nature Communications, 6(8644), 8644-1-8644-1 7.
DOI Scopus121 WoS116 Europe PMC105
2014 Kara, E., Comerford, I., Fenix, K., Bastow, C., Gregor, C., McKenzie, D., & McColl, S. (2014). Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathogens, 10(2), 1003905-1-1003905-15.
DOI Scopus77 WoS68 Europe PMC63
2013 Kara, E., Comerford, I., Bastow, C., Fenix, K., Litchfield, W., Handel, T., & McColl, S. (2013). Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. Journal of Immunology, 191(3), 1110-1117.
DOI Scopus59 WoS56 Europe PMC49
2010 Comerford, I., Bunting, M., Fenix, K., Haylock-Jacobs, S., Litchfield, W., Harata-Lee, Y., . . . McColl, S. (2010). An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation? CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays, 32(12), 1067-1076.
DOI Scopus106 WoS105 Europe PMC93
- Krishnan, S. T., Rudd, D., Rahmani, R., Antunez, E. E., Minhas, R. S., Kirana, C., . . . Voelcker, N. H. (2022). Nanostructured Silicon Enabled HR-MS for the Label-Free Detection of Biomarkers in Colorectal Cancer Plasma Small Extracellular Vesicles. Journal of Nanotheranostics, 3(4), 189-202.
DOI

Year Citation
2017 Gregor, C. E., Kara, E. E., Fenix, K. A., McKenzie, D. R., Comerford, I., & McColl, S. R. (2017). Effector T helper cell recruitment to inflammatory sites via CCR2. In SWISS MEDICAL WEEKLY Vol. 147 (pp. 64S). E M H SWISS MEDICAL PUBLISHERS LTD.

Year Citation
2016 McKenzie, D., Kara, E., Tyllis, T., Bastow, C., Fenix, K., Gregor, C., . . . McColl, S. (2016). Dynamic expression of CCR6 and CCR2 balances homeostatic and inflammatory trafficking of γδT17 cells. Poster session presented at the meeting of EUROPEAN JOURNAL OF IMMUNOLOGY. Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2016 Kara, E., Bastow, C., Mckenzie, D., Gregor, C., Fenix, K., Norton, T., . . . Mccoll, S. (2016). The atypical chemokine receptor ACKR4 shapes early antibody responses. Poster session presented at the meeting of EUROPEAN JOURNAL OF IMMUNOLOGY. Melbourne, AUSTRALIA: WILEY-BLACKWELL.

Year Citation
2026 Mai, L., Mai, L., Bouras, G., Yeo, K., Barry, E., Kulathunga, B., . . . Fenix, K. (2026). Genomic Signatures and Functional Pathways Underlying 5-Fluorouracil Resistance in Head and Neck Cancer associated Streptococci.
DOI
2026 King, C., Iqbal, M., Shokati, E., Ying Li, C. M., Li, R., Tomita, Y., . . . Fenix, K. (2026). Comparative benchmarking of single-cell transcriptomes and immune repertoires across technologies.
DOI
2024 Li, C. M. Y., Briggs, M., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
DOI
2024 Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease.
DOI
2024 Yeo, K., Connell, J., Bouras, G., Smith, E., Murphy, W., Hodge, J. -C., . . . Fenix, K. A. (2024). A comparison between full-length 16S rRNA Oxford Nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues.
DOI Europe PMC1
2024 Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?.
DOI
2024 Burdon, I., Bouras, G., Fenix, K., Yeo, K., Connell, J., Cooksley, C., . . . Psaltis, A. J. (2024). Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome.
DOI
2023 Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2023). Identification of consensus head and neck cancer-associated microbiota signatures: a meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets.
DOI
2023 Ying Li, C. M., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2023). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
DOI

Dr Kevin Fenix is a recipient of multiple competitive research funding awards (>$3million) from  MRFF, Cancer Council SA, Tour de Cure, Cure Cancer Australia, the Ray and Shirl Norman Trust, and The Hospital Research Foundation Group.

A selection of competitive funding awards are listed below:

Competitive Research Grants
Year Title Role Amount
2026 A Pilot Study for the IMPACT-CRC Trial: IMPlementAtion of Cytokine-Induced Killer Cell Therapy for Metastatic ColoRectal Cancer (MRFF:2045015) CIB $758,120
2024 Microbial infiltrates in head and neck cancers as mediators of chemotherapy responsiveness. (HSCGB Ray and Shirl Norman Cancer Research Trust) CIB $358,901
2024 Cytokine induced killer cell therapy as a treatment for metastatic colorectal cancer (Cancer Council SA Research Fellowship) CIA $480,000
2024 The development of more effective next-generation cytokine-induced killer cell therapies for the improved treatment of metastatic colorectal cancer (Cure Cancer) CIA $200,000
2020 Pre-clinical assessment of a patient-derived cellular immunotherapy for metastatic colorectal cancer. (Tour de Cure) CIA $50,000
2019 Construction of the South Australian Liver Tissue-Biobank (SALT) for discovery and development of prognostic biomarkers of colorectal cancer liver metastasis. (Beat Cancer SA and The Hospital Research Foundation) CIB $200,000
2018 Study of bioactivity of Hengshan Astragalus Shiitake as biological response modifiers in cancer therapy ( Flinders University Innovation Patnership Seed Grant and Shanxi Yulongxiang agricultural development Co., Ltd) CID $100,000
2018 Using Tissue-Resident T cells to develop new prognostics and treatments against bowel cancer. ( The Hospital Research Foundation Early Career Fellowship) CIA $240,000
Travel Awards
Year Source Conference Amount
2025 The Hospital Research Foundation Group (BHI  International Travel Award) International Congress of Immunology 2025 (Vienna, Austria) $2,500
2024 Adelaide Medical School and The Hospital Research Foundation Group (BHI  International Travel Award) European Association for Cancer Research Annual Scientific Conference (Rotterdam, Netherlands) and Laboratory Visits (Italy and Germany) $6,500
2022 The Hospital Research Foundation Group (BHI  National Travel Award) Annual Scientific Meeting of Australasian Society for Immunology (Melbourne, Australia) $500
2019 Faculty of Health and Medical Sciences Lorne Cancer Conference (2019) $1000
2017 Australasian Society for Immunology 46th Annual Scientific Meeting of Australasian Society for Immunology (Brisbane, Australia) $1400
2016 International Congress of Immunology International Congress of Immunology 2016 (Melbourne, Australia) $1000
2014 School of Molecular and Biomedical Science and Australasian Society for Immunology Annual Scientific Meeting of Australasian Society for Immunology (Wollongong, Australia) $1500

 

Date Role Research Topic Program Degree Type Student Load Student Name
2026 Principal Supervisor Investigating the Role of the Oral Microbiome in Treatment Response and Immune Modulation in Head and Neck Cancer Doctor of Philosophy Doctorate Full Time Ms Yue Feng
2026 Principal Supervisor Identify and Optimize Synergistic Combination Partners to Enhance CIK Infiltration and anti-Tumour Efficacy in Colorectal Cancers Doctor of Philosophy Doctorate Full Time Ms Bixi Kang
2026 Principal Supervisor Understanding the anti-cancer mechanisms of Cytokine-Induced Killer Cells in 3D Patient-Derived Colorectal Cancer Organoids Doctor of Philosophy Doctorate Full Time Mr Marzuq Mohammad Alam
2026 Principal Supervisor Understanding the anti-cancer mechanisms of Cytokine-Induced Killer Cells in 3D Patient-Derived Colorectal Cancer Organoids Doctor of Philosophy Doctorate Full Time Mr Marzuq Mohammad Alam
2025 Co-Supervisor Intra-tumoural and oral microbiome composition and oral cancer outcomes Master of Philosophy (Surgery) Master Full Time Mr Jonathan Daniel
2025 Co-Supervisor Intra-tumoural and oral microbiome composition and oral cancer outcomes Doctor of Philosophy Doctorate Full Time Mr Jonathan Daniel
2024 Principal Supervisor The development of more effective next-generation cytokine-induced killer cell therapies for the improved treatment of metastatic colorectal cancer Doctor of Philosophy Doctorate Full Time Mrs Elham Shokati
2023 Co-Supervisor Repurposing the anti-anginal drug perhexiline for the treatment of cancer Doctor of Philosophy Doctorate Full Time Ms Fangmeinuo Wu
2023 Principal Supervisor Target the tumour microbiome to improve head & neck cancer treatment outcomes Doctor of Philosophy Doctorate Full Time Ms Linh Mai
2022 Co-Supervisor The role of various Staphylococcus species in eliciting inflammation in Chronic rhinosinusitis Doctor of Philosophy Doctorate Full Time Mr Sintayehu Ambachew Wondemagegn
2022 Co-Supervisor Over-expression of SFRP5 in hepatocytes: a novel treatment strategy for colorectal cancer liver metastases Doctor of Philosophy Doctorate Full Time Mr Runhao Li

Date Role Research Topic Program Degree Type Student Load Student Name
2021 - 2024 Co-Supervisor Characterising the Microbiome and its Diagnostic and Prognostic Value in Head and Neck Cancer Doctor of Philosophy Doctorate Full Time Mr Kenny Ker Li Yeo
2021 - 2022 Co-Supervisor Perhexiline as a Potential Treatment for Colorectal Cancer Doctor of Philosophy Doctorate Full Time Mrs Bimala Dhakal
2020 - 2024 Co-Supervisor INVESTIGATION OF CYTOKINE-INDUCED KILLER CELL THERAPY FOR THE TREATMENT OF COLORECTAL CANCER LIVER METASTASIS Doctor of Philosophy Doctorate Full Time Miss Man Ying Li

Date Role Committee Institution Country
2026 - ongoing Member College of Health - Research Enablers Adelaide University Australia
2019 - ongoing Member BHI IBC Biosafety Committee BHI Australia
2018 - ongoing Member Basil-Hetzel Institute Management Committee Basil-Hetzel Institute for Translational Health Research Australia
2017 - ongoing Member Adelaide Immunology Retreat Organzing Committee Australasian Soceity for Immunology Australia
2017 - ongoing Member Day of Immunology (Adelaide) Organizing Committee Australsian Society for Immunology Australia

Date Role Membership Country
2018 - ongoing Member Australasian Cytometry Society Australia
2018 - ongoing Member Australasian Gastro-Intestinal Trials Group Australia
2018 - ongoing Member Cancer Voices SA Australia
2013 - ongoing Member Australasian Society for Immunology Australia

Date Title Engagement Type Institution Country
2018 - ongoing Invited Speaker for The Longest Table Events Public Community Engagement The Hospital Research Foundation Australia
2018 - ongoing Science Alive! Booth Volunteer (BHI) Public Community Engagement Basil Hetzel Institute for Translational Health Research Australia
2018 - ongoing Newsletter Article in The Hospital Research Foundation Public Community Engagement The Hospital Research Foundation -
2018 - ongoing Radio Interview for Coast FM Public Community Engagement The Hospital Research Foundation Australia
2018 - ongoing Invited Speaker for the Day of Immunology BHI Lab Tour Public Community Engagement Australasian Society for Immunology Australia

Date Role Editorial Board Name Institution Country
2018 - 2024 Editor Frontiers in Cellular and Infection Microbiology The University of Adelaide Australia

Connect With Me

External Profiles

Other Links